USPTO serial 98448985
NEUROTECH
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 28, 2026
- Examiner
- SCHLEGELMILCH, JONATHON A
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with NEUROTECH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Neurotech Pharmaceuticals, Inc.
Cumberland, RI, US
Neurotech Pharmaceuticals, Inc.
Cumberland, RI, US
Neurotech Pharmaceuticals, Inc.
Cumberland, RI, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Emilia F. Cannella
Emilia F. Cannella Ropes & Gray LLPPrudential Tower, 800 Boylston StreetBoston, MA 02199United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the prevention and treatment of ophthalmic diseases and disorders; intravitreal implants, namely, implantable drug delivery devices sold filled with a pharmaceutical for the treatment of eye and vision conditions | ACTIVE | Jun 4, 2025 |
| 010 | Medical devices for the prevention and treatment of ophthalmic diseases and disorders; medical device, namely, intraocular implant | ACTIVE | Jun 4, 2025 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Neurotech Pharmaceuticals, Inc.
- Other trademarks owned by Neurotech Pharmaceuticals, Inc.
- Other trademarks owned by Neurotech Pharmaceuticals, Inc.
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named NEUROTECH
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 28, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Apr 28, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 7, 2026 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Apr 7, 2026 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Apr 3, 2026 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Apr 3, 2026 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Oct 7, 2025 | IUAF | USE AMENDMENT FILED | — |
| Oct 7, 2025 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| May 27, 2025 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 1, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 1, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 26, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 5, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 5, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 5, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 5, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 5, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 12, 2024 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Dec 12, 2024 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Sep 26, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 26, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 26, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 24, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 6, 2024 | MDSM | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Aug 6, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 14, 2024 | NWAP | NEW APPLICATION ENTERED | — |